Cutting-Edge CDMO Insights: Navigating the Evolving Biopharma Landscape
The biopharmaceutical industry is undergoing significant transformations, driven by the increasing complexity of novel therapies, global supply chain uncertainties, and intensified regulatory scrutiny. Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this evolution, as they must deliver…